| Probing the activation-promoted structural rearrangements in preassembled receptor–G protein complexes C Galés, JJJ Van Durm, S Schaak, S Pontier, Y Percherancier, M Audet, ... Nature structural & molecular biology 13 (9), 778-786, 2006 | 539 | 2006 |
| Real-time monitoring of ubiquitination in living cells by BRET J Perroy, S Pontier, PG Charest, M Aubry, M Bouvier Nature Methods 1 (3), 203-208, 2004 | 196 | 2004 |
| Cholesterol-dependent separation of the β2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction SM Pontier, Y Percherancier, S Galandrin, A Breit, C Galés, M Bouvier Journal of biological chemistry 283 (36), 24659-24672, 2008 | 147 | 2008 |
| β1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression L Huck, SM Pontier, DM Zuo, WJ Muller Proceedings of the National Academy of Sciences 107 (35), 15559-15564, 2010 | 143 | 2010 |
| Integrins in mammary-stem-cell biology and breast-cancer progression–a role in cancer stem cells? SM Pontier, WJ Muller Journal of cell science 122 (2), 207-214, 2009 | 108 | 2009 |
| Coordinated action of NSF and PKC regulates GABAB receptor signaling efficacy SM Pontier, N Lahaie, R Ginham, F St‐Gelais, H Bonin, DJ Bell, H Flynn, ... The EMBO Journal 25 (12), 2698-2709, 2006 | 58 | 2006 |
| Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer SM Pontier, L Huck, DE White, J Rayment, V Sanguin-Gendreau, ... Oncogene 29 (23), 3374-3385, 2010 | 56 | 2010 |
| Glycosphingolipids in signaling and development: from liposomes to model organisms SM Pontier, F Schweisguth Developmental Dynamics 241 (1), 92-106, 2012 | 48 | 2012 |
| Enterobacteria and host resistance to infection E Kang, A Crouse, L Chevallier, SM Pontier, A Alzahrani, N Silué, ... Mammalian genome 29, 558-576, 2018 | 46 | 2018 |
| Allosteric effects of G protein overexpression on the binding of β-adrenergic ligands with distinct inverse efficacies M Azzi, G Piñeyro, S Pontier, S Parent, H Ansanay, M Bouvier Molecular pharmacology 60 (5), 999-1007, 2001 | 46 | 2001 |
| G protein stoichiometry dictates biased agonism through distinct receptor-G protein partitioning L Onfroy, S Galandrin, SM Pontier, MH Seguelas, D N’Guyen, JM Sénard, ... Scientific Reports 7 (1), 7885, 2017 | 42 | 2017 |
| Integrins in breast cancer dormancy SM Pontier, WJ Muller Apmis 116 (7‐8), 677-684, 2008 | 35 | 2008 |
| Implications of Spatiotemporal Regulation of Shigella flexneri Type Three Secretion Activity on Effector Functions: Think Globally, Act Locally FX Campbell-Valois, SM Pontier Frontiers in Cellular and Infection Microbiology 6, 28, 2016 | 29 | 2016 |
| A Wolbachia-sensitive communication between male and female pupae controls gamete compatibility in Drosophila SM Pontier, F Schweisguth Current Biology 25 (18), 2339-2348, 2015 | 25 | 2015 |
| A Tale about Shigella: Evolution, Plasmid, and Virulence N Haidar-Ahmad, FO Manigat, N Silué, SM Pontier, FX Campbell-Valois Microorganisms 11 (7), 1709, 2023 | 1 | 2023 |
| Response to “does pupal communication influence Wolbachia-mediated cytoplasmic incompatibility?” SM Pontier, F Schweisguth Current Biology 27 (2), R55-R56, 2017 | | 2017 |
| NOUVEAUX MECANISMES DE REGULATION DES RECEPTEURS COUPLES AUX PROTEINES G: LIEN ENTRE COMPLEXES PROTEIQUES, LOCALISATION ET SIGNALISATION SM PONTIER | | 2005 |
| 6.2 Deuxième article V Bernier, SM Pontier, PG Charest, DG Bichet, IV Bouvier Des chaperons pharmacologiques agissant sur les récepteurs V2 de la …, 2004 | | 2004 |
| ACTION MECHANISM OF PHARMACOLOGICAL CHAPERONES ACTING ON THE V2 VASOPRESSIN RECEPTOR V Bernier, S Pontier, P Charest, J Perroy, D Bichet, M Bouvier Clinical and Experimental Pharmacology and Physiology 31, 2004 | | 2004 |
